Skip to Content

Join the 'Pain Killer' group to help and get support from people like you.

Pain Killer News

Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties

Posted 30 Apr 2016 by Drugs.com

CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone) extended-release (ER) capsules CII, a twice-daily, oxycodone medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Xtampza ER is Collegium’s first product utilizing its proprietary DETERx® technology platform, and is designed to provide adequate pain control while maintaining its drug release profile after being subjected to common methods of manipulation including chewing and crushing the product prior to administration. The Xtampza ER label contains information supporting the administration of the product by sprinkling the capsule contents on soft foods or into a cup, and th ... Read more

Related support groups: Pain, Oxycodone, Narcotic, Pain Medication, Pain Management, Pain Relief, Pain Pill, Opioid, Pain Killer, Xtampza ER

Ask a Question